首页> 外国专利> PROTEOMIC ANALYSIS OF CERVICAL-VAGINAL FLUIDS FOR DETECTING INTRA-UTERINE INFECTION OR DETERMINING PRE-TERM DELIVERY RISK IN A PREGNANT FEMALE

PROTEOMIC ANALYSIS OF CERVICAL-VAGINAL FLUIDS FOR DETECTING INTRA-UTERINE INFECTION OR DETERMINING PRE-TERM DELIVERY RISK IN A PREGNANT FEMALE

机译:宫颈阴道液的蛋白质组学分析,用于检测子宫内感染或确定孕妇的早产风险

摘要

The invention concerns the identification of proteomes of biological fluids and their use in determining the state of maternal/fetal conditions, including maternal conditions of fetal origin, chromosomal aneuploidies, and fetal diseases associated with fetal growth and maturation. In particular, the invention concerns a comprehensive proteomic analysis of human amniotic fluid (AF) and cervical vaginal fluid (CVF), and the correlation of characteristic changes in the normal proteome with various pathologic maternal/fetal conditions, such as intra-amniotic infection, pre-term labor, and/or chromosomal defects. The invention further concerns the identification of biomarkers and groups of biomarkers that can be used for non-invasive diagnosis of various pregnancy-related disorders, and diagnostic assays using such biomarkers.
机译:本发明涉及生物流体蛋白质组的鉴定及其在确定母体/胎儿状况的状态中的用途,所述母体/胎儿状况包括胎儿来源的母体状况,染色体非整倍性以及与胎儿生长和成熟有关的胎儿疾病。具体而言,本发明涉及对人羊水(AF)和宫颈阴道液(CVF)的综合蛋白质组学分析,以及正常蛋白质组特征变化与各种病理性母体/胎儿状况(例如羊膜内感染)的相关性,早产和/或染色体缺陷。本发明进一步涉及可用于非侵入性诊断各种与妊娠有关的疾病的生物标记物和生物标记物组的鉴定,以及使用此类生物标记物的诊断测定。

著录项

  • 公开/公告号EP2092344A2

    专利类型

  • 公开/公告日2009-08-26

    原文格式PDF

  • 申请/专利权人 PROTEOGENIX INC.;

    申请/专利号EP20070871428

  • 申请日2007-11-09

  • 分类号G01N33/68;

  • 国家 EP

  • 入库时间 2022-08-21 19:15:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号